Large majorities of Republican primary voters want the Trump administration to crack down on the distribution of the abortion pill by mail and say they would be less enthusiastic to vote in the midterm elections if GOP leaders shy away from pro-life policies, according to new polling. 
Over 70% of GOP primary voters oppose a Biden-era policy that allowed the abortion pill mifepristone to be shipped through the mail without any in-person doctor visit, according to <a href="https://sbaprolife.org/wp-content/uploads/2026/02/SBA_National_Memo_Final.pdf">polling</a> conducted by Cygnal. That included 77% of self-identified Trump voters and 76% of voters who said they supported the Make America Healthy Again movement. The polling surveyed 1,000 GOP primary voters across the country from February 8-10. 
The polling comes after lawmakers like <a href="https://www.dailywire.com/news/serious-crisis-hawley-says-congress-must-act-to-combat-rising-abortion-rates?author=Leif+Le+Mahieu&amp;category=News&amp;elementPosition=undefined&amp;row=0&amp;rowType=Vertical+List&amp;title=%E2%80%98Serious+Crisis%E2%80%99%3A+Hawley+Says+Congress+Must+Act+To+Combat+Rising+Abortion+Rates">Senator Josh Hawley</a> (R-MO) and pro-life groups have called for the Department of Health and Human Services and the Food and Drug Administration to end the Biden-era provision that has allowed abortion drugs to flood into red states where medication abortions are technically illegal. 
Mifepristone cuts off the nutrients that an unborn child needs to survive in the womb. Another drug is then taken to expel the deceased baby from the mother. 
Pro-life advocates say that failure to act could cause a lack of enthusiasm from pro-life voters, who constitute a significant portion of the GOP base. 
“The failure to rein in abortion drugs risks base enthusiasm this November,” said Susan B. Anthony Pro-Life America President Marjorie Dannenfelser during a Thursday press call attended by The Daily Wire, discussing the polling. “You cannot win without your base. You can&#8217;t bring together that handful of votes in battlegrounds that are required. The abortion drug problem is an electoral problem in addition to a moral problem in our nation, and it&#8217;s caused by the lack of leadership at HHS.”
Nearly a third (32%) of GOP primary voters said they would have decreased enthusiasm to vote in the midterm elections if Republican leaders weakened their stance on the issue of life. Another 34% said they would be less likely to volunteer and help out with campaigns. 
Cygnal pollster John Rogers said that a drop in enthusiasm could have a “dramatic effect across the board” in key midterm elections. 
When asked about the polling, White House spokeswoman Olivia Wales highlighted pro-life policies enacted by President Donald Trump.
“President Trump is the most pro-life and pro-family President in history. Thanks to the President’s appointments to the United States Supreme Court, Roe v. Wade was correctly overturned – a triumphant victory for life,&#8221; she told The Daily Wire. &#8220;The President has also enforced the Hyde Amendment and reinstated the Mexico City Policy to end taxpayer-funded abortion at home and abroad, expanded child tax credits, created Trump Accounts, and established a rigorous, Gold Standard Science safety review of mifepristone by the FDA.&#8221;
Wales added that the Trump administration would continue to pursue pro-life policies.
&#8220;President Trump and his entire administration will continue to boldly advance policies that protect the most vulnerable among us and promote the growth and success of America’s families,&#8221; she said. 
Both FDA Commissioner Marty Makary and HHS Secretary Robert F. Kennedy Jr. <a href="https://www.dailywire.com/news/pro-lifers-demand-answers-from-trump-admin-after-shocking-abortion-pill-approval">said</a> that they are conducting a study on the abortion pill, but lawmakers and advocates have grown impatient. In September, the FDA shocked pro-life advocates by approving another generic brand of mifepristone. 
The Cygnal polling found that 80% of primary voters wanted the FDA to require in-person doctor visits to get the abortion pill, and another 72% oppose approving generic forms of mifepristone before the completion of a safety study. Sixty-five percent disapproved of HHS’s handling of the abortion issue. 
Despite the overturning of Roe, abortions across the country have <a href="https://www.dailywire.com/news/despite-dobbs-more-babies-are-still-being-aborted-in-the-united-states">increased</a>, fueled in large part by mail-order abortions. Data shows that there have been tens of thousands of abortions in states like Texas and Louisiana, where medication abortions are banned. 
“Pro-life protections passed at the state level are being completely undermined, stealing sovereignty away from pro-life states who have passed strong pro-life protections,” Dannenfelser said Thursday.
Last week, Hawley told The Daily Wire after a phone call with Makary that he thought it was time for Congress to take action.
“I think Congress needs to be involved. Congress shouldn’t be a spectator and just outsource this to other people,&#8221; he said. &#8220;I think it’s time for Congress to get involved.&#8221;

March for Life 2026

Republican Voters Want Action On Mail-Order Abortion Pill As Midterms Loom

Abortion

Abortion Drug

Department of Health and Human Services

Josh Hawley

Pro-Life Movement

The Trump administration appears to be gearing up for a substantial response to Iran, Washington state allegedly spends millions on gender surgeries for inmates, and whiplash hits Moderna as the Food and Drug Administration reverses its decision not to review the company’s new flu vaccine.
It’s Thursday, February 19, 2026, and this is the news you need to know to start your day. Today’s edition of the Morning Wire podcast can be heard below:
<iframe style="width: 100%; max-width: 660px; overflow: hidden; border-radius: 10px;" src="https://embed.podcasts.apple.com/us/podcast/iran-response-imminent-gender-surgeon-scrutinized-2-19-26/id1576594336?i=1000750462173" height="175" frameborder="0" sandbox="allow-forms allow-popups allow-same-origin allow-scripts allow-storage-access-by-user-activation allow-top-navigation-by-user-activation"></iframe>
<h2 style="text-align: center;">U.S. Surrounds Iran</h2>
Amid escalating tensions over Iran’s pursuit of nuclear weapons and the killings of thousands of protesters, the Trump administration appears to be gearing up for an armed response. 
Over the last 36 hours, the Middle East has seen the largest military buildup in decades. Hundreds of cargo flights have transported weapons systems to the region, as hundreds of fighter jets, dozens of warships, and multiple aircraft carrier groups have also made their way towards Iran. 
This may be a negotiating tactic by the United States to secure concessions from Tehran as diplomatic talks continue. But numerous advisers to President Donald Trump, <a href="https://x.com/rcpvideo/status/2024169941696459097?s=20">including</a> his former Secretary of State Mike Pompeo, said they don’t think it’s a bluff. Trump reportedly feels emboldened by the success of his bombing raid on Iran’s nuclear facilities back in June and the operation to grab Venezuelan dictator Nicolás Maduro in January. 
As one former American diplomat put it to The Wall Street Journal, the president’s offer to Iran “is similar to Venezuela, surrender and we won’t attack you.”
<h2 style="text-align: center;">Blue State Spends Millions On Gender Surgeon</h2>
A new investigation found that Washington state has spent millions on the services of a gender surgeon who performs surgeries on prison inmates. 
The Washington State Healthcare Authority has paid more than $4.3 million since July 2019 for the services of Dr. Jeffrey Stiller. 
He is a prolific transgender surgeon, and according to his website, he&#8217;s performed more than 1,000 vaginoplasties, averaging five procedures per week, describing his services as extremely sought-after. 
Importantly, for this investigation, public records obtained by The Daily Wire show that Dr. Stiller&#8217;s clientele included a steady stream of inmates from Washington Department of Corrections facilities.
<h2 style="text-align: center;">FDA’s Moderna Reversal</h2>
There’s whiplash at Moderna as the Food and Drug Administration reverses its decision not to review the company’s new flu vaccine. 
The FDA decided it will allow Moderna to move forward with its new mRNA flu vaccine. The agency blocked it last week, but allowed it to move forward again after the pharma company agreed to additional testing. 
The vaccine is expected to be brought to market in two phases: the first for people 65 and older through a process of “accelerated approval,” which will allow it to move forward with limited evidence. The vaccine for that cohort can later receive full approval with more tests. After those are completed, the vaccine will also be released for adults ages 50-64, assuming the results of those tests come back positive.

MW_260219_V1

Morning Brief: U.S. Surrounds Iran, Prisoners Get ‘Gender Surgeries,’ & FDA’s Moderna Reversal

Donald Trump

Iran

Moderna

Morning Wire

United States

Washington

After a closed-door hearing this week with Food and Drug Commissioner Marty Makary, Senator Josh Hawley told The Daily Wire that Congress must take action against rising abortion rates largely fueled by the abortion drug mifepristone. 
Hawley and other senators on the Senate Health, Education, Labor, and Pension (HELP) Committee met with Makary on Tuesday for a private briefing on mifepristone. The briefing focused on the FDA’s handling of mifepristone and an ongoing study of the drug&#8217;s safety. 
Both Makary and Health and Human Services (HHS) Secretary Robert F. Kennedy Jr. committed to conducting the study last year, but Republican lawmakers have grown impatient. 
“I think we&#8217;re at a dead end on this process with the safety review. I just don&#8217;t think it&#8217;s going anywhere, and I think the fact that 70% of abortions in this country now are done with the chemical abortion drug, there are more abortions in America now than there were when Roe was still the law of the land just a few years ago,” Hawley told The Daily Wire. “We have a serious, serious crisis around the chemical abortion drug, and we&#8217;ve got to do something about it.”
Data released in December by the pro-abortion Society of Family Planning <a href="https://societyfp.org/research/wecount/wecount-june-2025-data/">revealed</a> that the number of monthly abortions continued to increase in 2025 from 2024, which was itself an increase from 2023. Many of the pills have been sent through the mail to states where medication abortions are technically illegal. 
Hawley said he has not heard back from the FDA on any of the letters sent on the abortion pill and said he didn’t receive any new information on Wednesday. He said there was no “sense of urgency” to take any action.
“I think this study is just a dead end,” he said. “I think Congress needs to act.”
Hawley said he was still contemplating what the action might look like, but any pro-life proposal would face an uphill battle in the Senate. 
“I think Congress needs to be involved. Congress shouldn&#8217;t be a spectator and just outsource this to other people. I think it&#8217;s time for Congress to get involved,” he said. 
At a minimum, Hawley says the FDA should reverse a Biden-era decision that allowed mifepristone to be shipped through the mail without an in-person doctor visit. Pro-life advocates say that the policy effectively nullifies the laws of states that have cracked down on abortion pills. 
When reached for comment, the FDA pointed The Daily Wire to a <a href="https://www.fda.gov/drugs/postmarket-drug-safety-information-patients-and-providers/questions-and-answers-mifepristone-medical-termination-pregnancy-through-ten-weeks-gestation">Q&amp;A page</a> on mifepristone.

Telecommunications Executives Testify In Senate Hearing Examining Arctic Frost Investigation

‘Serious Crisis’: Hawley Says Congress Must Act To Combat Rising Abortion Rates

A transgender-identifying man commits one of the deadliest mass shootings in Canada’s history, Ohio Republicans move to protect parents who rebuff the concept of gender identity, and the Food and Drug Administration zeroes in on chemical preservatives in American foods.
It’s Thursday, February 12, 2026, and this is the news you need to know to start your day. Today’s edition of the Morning Wire podcast can be heard below:
<iframe style="width: 100%; max-width: 660px; overflow: hidden; border-radius: 10px;" src="https://embed.podcasts.apple.com/us/podcast/trans-shooter-claims-lives-parental-rights-gain-traction/id1576594336?i=1000749409417" height="175" frameborder="0" sandbox="allow-forms allow-popups allow-same-origin allow-scripts allow-storage-access-by-user-activation allow-top-navigation-by-user-activation"></iframe>
<h2 style="text-align: center;">Canada School Mass Shooting</h2>
At least nine people are dead and dozens more wounded after a mass shooting in British Columbia, Canada. The shooting is one of the deadliest in Canada’s history. 
The shooter, whom police initially described as a “gunperson” in a “dress,” appears to have killed at least eight people across two locations and wounded dozens. That person has now been <a href="https://www.dailywire.com/news/youtube-confirms-trans-themed-page-is-linked-to-canada-mass-shooting-suspect?topStoryPosition=undefined&amp;author=Leif+Le+Mahieu&amp;category=News&amp;elementPosition=0&amp;row=1&amp;rowHeadline=Top+Stories&amp;rowType=Top+Stories&amp;title=Deadly+Canada+School+Attacker+Was+Trans+Identifying+Man%2C+Police+Confirm">identified</a> as an 18-year-old male named Jesse Van Rootselaar, who identified as a female and had a history of mental illness.
&#8220;I will say this, we identify the suspect as they chose to be identified in public and on social media,&#8221; said Royal Canadian Mounted Police Deputy Commissioner Dwayne McDonald. &#8220;I can say that Jesse was born as a biological male who approximately six years ago began to transition to female and identified as female, both socially and publicly.&#8221;
 Two people were found dead inside a local home, who have since been identified as the shooter’s mother and 11-year-old brother. Most of the carnage took place at Tumbler Ridge Secondary School, located in a remote area of northeastern British Columbia. There, at least six others were found dead, including the suspect. One more person died while they were being taken to a hospital. Students at the school said they were forced to barricade themselves in classrooms for roughly two-and-a-half hours before they were evacuated by police.
<h2 style="text-align: center;">Ohio Lawmakers Take On Gender Ideology</h2>
In the red state of Ohio, parents can lose custody of their children for refusing to affirm their “gender identity.” But Republicans are looking to change that. 
Ohio is one of many states where child welfare agencies have embraced radical gender ideology. Some parents of gender-confused kids who insist on referring to their child’s biological sex and given name could be labeled as “abusive” or “neglectful” by the state. This could mean being investigated and even losing custody of their children. 
The Republican-backed bill is called &#8220;The Affirming Families First Act,&#8221; as in, affirming the child’s natural family rather than a gender-affirming family found by the state. The bill would ensure that parents could not be accused of <a href="https://www.dailywire.com/news/biden-harris-hhs-consulted-activist-who-said-parents-should-be-prosecuted-for-transphobia?author=Spencer+Lindquist&amp;category=News&amp;elementPosition=8&amp;row=0&amp;rowType=Vertical+List&amp;title=Biden-Harris+HHS+Consulted+Activist+Who+Said+Parents+Should+Be+Prosecuted+For+%E2%80%98Transpho">abuse</a> or acting “contrary to the best interest of the child” by any state agency simply for affirming the child’s actual sex.
<h2 style="text-align: center;">FDA Reviews Food Preservatives Found In Rubber</h2>
The FDA is zeroing in on chemical food preservatives and making changes to food labels, <a href="https://www.dailywire.com/news/fda-probes-use-of-food-preservative-also-used-in-rubber-and-plastic?author=Tim+Pearce&amp;category=News&amp;elementPosition=0&amp;row=0&amp;rowType=Vertical+List&amp;title=FDA+Probes+Use+Of+Food+Preservative+Also+Used+In+Rubber+And+Plastic">aiming</a> to bring American food more in line with European standards and make labels clearer. The agency announced on Tuesday that it plans to review a preservative called BHA, which is commonly used in many processed foods. FDA Commissioner Dr. Marty Makary says that the preservative may contribute to cancer. 
“About 4,600 different types of food that are common in the U.S. Food supply have BHA. It&#8217;s an ingredient that&#8217;s found in rubber, in plastic, in glue,” Makary told Morning Wire. “A National Toxicology Program assessment said that there&#8217;s a reasonable anticipation that it&#8217;s carcinogenic or cancer-causing.”
The FDA is also rolling out new rules regarding food labels, specifically regarding claims around artificial dyes. 
“The FDA is making it very clear what these labels should mean, and what the criteria are. For example, the label, ‘no artificial dyes’ will now mean no artificial dyes. In the past, if you used a natural dye from natural ingredients, you could not use that label, and it created a lot of confusion among parents shopping for groceries for their kids,” said Makary.

Tumbler Ridge secondary school

Morning Brief: Trans-Identifying Man Behind Canada School Shooting & Ohio Battles Gender Ideology

Canada

Ohio

Transgender

The FDA is zeroing in on chemical food preservatives and making changes to food labels, aiming to bring American food more in line with European standards and make labels clearer.
The agency announced on Tuesday that is plans to review a preservative called BHA, which is commonly used in many processed foods. FDA commissioner Dr. Marty Makary says that the preservative may contribute to cancer.
“About 4,600 different types of food that are common in the U.S. Food supply have BHA. It&#8217;s an ingredient that&#8217;s found in rubber, in plastic, in glue,” Makary told The Daily Wire. “A National Toxicology Program assessment said that there&#8217;s a reasonable anticipation that it&#8217;s carcinogenic or cancer-causing.”
In addition to BHA, the FDA is also taking a closer look at two other compounds called BHT and azodicarbonamide.
“BHT is very common in cereal. It&#8217;s known to be a hormone disruptor,” Makary said, “and azodicarbonamide, which is a dough conditioner, is what gives yoga mats the sort of air bubbles to give it the cushion.”
“It&#8217;s also used in shoes to make them more springy. And it&#8217;s also found in breads and foods, and it just doesn&#8217;t make sense that the same chemicals used to condition yoga mats and shoes are also being used in food for children,” the commissioner said.
The chemicals under review have already been banned by most of Europe. They became staples of processed foods in the United States because they were protected under an FDA rule known as GRAS, or generally recognized as safe. The rule allowed companies to self-declare chemicals as safe.
“It was originally intended for things like salt, and things that were naturally in the environment, but companies over time used this loophole to be able to self declare chemicals as safe without any real good, solid testing, and then just insert them into the food, not because it added any taste or flavor, but because it increased the shelf life of certain foods,” said Makary.
“Now that this medical field has matured and caught up. The data now shows that there are health concerns with some of these chemicals,” he added.
Alternatives to these popular preservatives are cost neutral, according to Makary, so replacing them will not place any additional costs on companies.
The FDA is also rolling out new rules regarding food labels, specifically regarding claims around artificial dyes.
“The FDA is making it very clear what these labels should mean, and what the criteria are. For example, the label, ‘no artificial dyes’ will now mean no artificial dyes. In the past, if you used a natural dye from natural ingredients, you could not use that label, and it created a lot of confusion among parents shopping for groceries for their kids,” said Makary.
“Now, you can trust that label, ‘no artificial dyes.’ And at the same time, the FDA approved last week two new natural dyes that can be used as alternatives to the petroleum artificial dyes, and that&#8217;s what we need to do,” he added.

Marty Makary

FDA Probes Use Of Food Preservative Also Used In Rubber And Plastic

Online telehealth company Hims &amp; Hers on Saturday reversed course on its launch of a $49 compounded version of Novo Nordisk&#8217;s Wegovy weight-loss pill after the U.S. Food and Drug Administration said it would take action against it.
&#8220;Since launching the compounded semaglutide pill on our platform, we’ve had constructive conversations with stakeholders across the industry. As a result, we have decided to stop offering access to this treatment,&#8221; the telehealth firm said.
The FDA said on Friday that it plans to restrict GLP-1 ingredients used in compounded drugs that companies such as Hims and online pharmacies have marketed, citing concerns over quality, safety and potential violations of federal law.
The Department of Health and Human Services said on Friday it would refer the company to the Department of Justice but did not make clear whether it could quickly halt the sale of the Hims&#8217; product, the cheapest GLP-1 therapy on the U.S. market.
Reuters reported on Thursday that Hims would begin offering copies of Novo Nordisk&#8217;s new Wegovy pill at an introductory price of $49 per month, about $100 less than the brand name.
The news caused a selloff in shares of Novo and rival Eli Lilly, whose own pill is expected to launch in April. The shares recovered some of the losses on Friday after FDA Commissioner Dr. Marty Makary tweeted his concern after the market&#8217;s close on Thursday while Hims&#8217; shares fell.
&#8220;No one should be mass-compounding or selling knockoff GLP-1 products regardless of how they’re administered,&#8221; a Lilly spokesperson said in a statement to Reuters on Saturday after Hims &amp; Hers said it would stop offering its GLP-1 pill.
Compounding, in which pharmacies mix ingredients for specialized medicines or to copy a drug but at different dosages, has flourished as Americans chase cheaper prices for drugs. The practice is legal under the Federal Food, Drug and Cosmetic Act in certain circumstances.
Novo on Thursday responded to Hims&#8217; launch by threatening legal action against the company while Lilly, which has battled compounded copies of its injectable drug Zepbound, said that patients deserved better than copies with no clinical evidence.
Hims&#8217; compounded drug is not FDA-approved and has not gone through clinical trials to prove efficacy.
Novo did not immediately respond to a Reuters request for comment on Saturday.
Hims &amp; Hers did not respond to a Reuters query about whether it would continue selling compounded semaglutide injections on its website. The company, alongside Novo and Lilly, is spending millions during Sunday&#8217;s Super Bowl to promote its offerings.
Novo has been losing share in the weight-loss market to rival Lilly and telehealth firms like Hims. Novo and Hims had a partnership in 2025 allowing Hims to sell injectable Wegovy, but the two companies walked away with Novo saying Hims had wrongfully marketed copycats of Wegovy. Hims&#8217; CEO Andrew Dudum accused Novo of attempting to control how clinicians at Hims make decisions.
Makary said in a statement on Friday that the agency will &#8220;use all available compliance and enforcement tools within its authorities to address unsubstantiated claims and associated public health concerns.&#8221;
HHS, which oversees the FDA, was not immediately available for comment.
(Reporting by Anusha Shah and Amina Niasse; Editing by Caroline Humer and Andrea Ricci)

Hims Drops Fat-Loss Pill After FDA Warning

Health

Ozempic

U.S.

weight Loss

The U.S. Food and Drug Administration said on Friday it would take action against telehealth provider Hims &amp; Hers for its $49 weight-loss pill, including restricting access to the drug&#8217;s ingredients and referring the company to the Department of Justice for potential violations of federal law.
Federal action to limit the production of compounded drugs would be a win for Novo Nordisk, which has been losing share in the weight-loss market to rival Eli Lilly and telehealth firms like Hims. However, the FDA did not make clear whether it could quickly halt the sale of Hims&#8217; product, the cheapest GLP-1 therapy on the U.S. market.
Shares of Hims fell 14.1% in after-hours trade.
The FDA said it plans to restrict GLP-1 ingredients used in non-approved compounded drugs that companies such as Hims and other compounding pharmacies have marketed as alternatives to authorized treatments. The agency cited concerns over quality, safety and potential violations of federal law.
On Thursday, Reuters was first to report that Hims would begin offering copies of Novo Nordisk&#8217;s new Wegovy pill at an introductory price of $49 per month, about $100 less than the brand name.
Novo Nordisk later said it would take legal action against the telehealth company over its plan to sell compounded copies of the drug.
The U.S. Department of Health and Human Services&#8217; General Counsel, Mike Stuart, also said on Friday he has referred Hims &amp; Hers to the Department of Justice for investigation over potential violations.
Hims said in a statement that the company &#8220;has always operated with a deep commitment to the safety and best interests of consumers and in compliance with applicable law.
&#8220;We have a long history of successfully working with regulators, and look forward to continuing to engage with the FDA to ensure safe access to affordable healthcare.&#8221;
A Lilly spokesperson said the company applauded the FDA action. &#8220;For years, compounders have been putting patients at risk by unlawfully mass-producing knockoff drugs using substandard ingredients from illicit foreign suppliers and selling them without clinical evidence that they’re safe or even work. Patients deserve better, and we look forward to decisive action by FDA, other regulators, and law enforcement.”
Compounding, in which pharmacies mix ingredients for specialized medicines or to copy a drug but at different dosages, has flourished as Americans chase cheaper prices for drugs.
The practice is legal under the Federal Food, Drug and Cosmetic Act in certain circumstances, like when prescribed by a physician to address patient side effects or during a drug shortage.
Hims&#8217; compounded drug is not FDA-approved and has not gone through clinical trials to prove efficacy.
The FDA&#8217;s enforcement actions against Hims could include sending a warning letter, pursuing a court injunction or conducting an administrative seizure of products, said Joanne Hawana, a member at Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C.
The agency would need the help of the Justice Department to pursue an injunction, as it lacks independent litigation authority, Hawana said.
The FDA&#8217;s statements suggest that &#8220;this announcement by Hims, to the government, is concerning enough that they decided they’re going to escalate,&#8221; Hawana said.
Thus far, the FDA&#8217;s actions on weight-loss drugs have been limited to warning letters sent in the fall of 2025 to combat misleading direct-to-consumer advertising and marketing.
Commissioner Marty Makary said in a statement on Friday that the agency will &#8220;use all available compliance and enforcement tools within its authorities to address unsubstantiated claims and associated public health concerns.&#8221;
The health regulator said that, in promotional materials, companies cannot claim that non-FDA-approved compounded products are generic versions or the same as drugs approved by FDA.
It added that &#8220;they also cannot state compounded drugs use the same active ingredient as the FDA-approved drugs or that compounded drugs are clinically proven to produce results for the patient.&#8221;
(Reporting by Siddhi Mahatole in Bengaluru and Leah Douglas in Washington; additional reporting by Amina Niasse in New York; Editing by Alan Barona and David Gregorio)

Pharmaceutical Companies in India

Hims Stock Tumbles As FDA Targets Its Discounted Weight-Loss Drugs

Prescription Drugs

The Justice Department said Tuesday that Food and Drug Administration (FDA) regulations allowing the abortion pill mifepristone to be shipped through the mail do not infringe on a state’s ability to protect the unborn.
The position was taken in a <a href="https://storage.courtlistener.com/recap/gov.uscourts.lawd.213952/gov.uscourts.lawd.213952.51.0_1.pdf">court filing</a> asking a judge not to grant a request from Louisiana to block the current regulations that allow mifepristone to be sent through the mail. The filing said that the FDA was currently reviewing the safety standards for mifepristone, and a ruling blocking the current standard could be “disruptive.” 
“Louisiana suffers no sovereign injury because it remains free to make and enforce its pro-life policies after Dobbs v. Jackson Women’s Health Org,” the Justice Department said. “Nor are Defendants standing in the way of Louisiana enforcing its abortion laws against out-of- state prescribers of mifepristone.”
Louisiana and a woman named Rosalie Markezich sued the FDA last November, seeking to have a judge suspend the FDA’s current Risk Evaluation and Mitigation Strategy standards for mifepristone. Markezich says she was coerced into taking abortion pills illegally ordered and sent into Louisiana by her ex-boyfriend. 
A White House official told The Daily Wire that nothing in the filing should be construed as the White House “defending&#8221; former President Joe Biden&#8217;s administration&#8217;s abortion drug policies.
“We’ve been very clear we have issues with that as well,” the White House official noted, saying that the Trump administration has raised issues with mifepristone, which is why it was conducting a study into mifepristone. 
“Legally speaking, it’s a question of standing,” the official said. “All we are really saying with this filing is, let’s not short-circuit this process, and let the agency, that is doing what a lot of the pro-life groups want, let them do what they’ve been tasked to do, and let that process play out.” 
As The Daily Wire <a href="https://www.dailywire.com/news/how-a-leftist-network-of-websites-floods-red-states-with-abortion-pills-with-no-consequences-2">previously reported</a>, leftist activists have been shipping abortion pills into states all across the country, even in red states like Louisiana, where medication abortions are technically illegal. This mailing of abortion pills, which was greenlit by the Biden administration as a COVID measure, has <a href="https://www.dailywire.com/news/despite-dobbs-more-babies-are-still-being-aborted-in-the-united-states">fueled an increase</a> in abortions across the country after Roe v. Wade was overturned by the Supreme Court. 
Shield laws passed in states like California and New York have been enacted, preventing Republican attorneys general from being able to prosecute the doctors sending abortion pills into their states. States like Louisiana say the FDA regulations give pro-abortion doctors the cover to ship the pills. 
Both FDA Commissioner Marty Makary and Health and Human Services Secretary Robert F. Kennedy Jr. have said that they are conducting a study on the abortion pill, but pro-life advocates and lawmakers have demanded quicker action. 
“Given this widespread debate over the safety of mifepristone, FDA has concluded that the best path forward is for the agency to reconsider the restrictions on mifepristone based on all the evidence before the agency,” the Justice Department said on Tuesday. “As noted above, that evidence will include FDA’s own study.”
The department also said that a ruling by a judge to block the current mifepristone regulations would “threaten to short circuit the agency’s orderly review and study of the safety risks of mifepristone by asking this Court for an immediate stay of the 2023 REMS Modification approved three years ago.”
When reached for comment, the Justice Department said that it was committed to President Donald Trump&#8217;s pro-life agenda.
“This Department of Justice remains committed to advancing President Trump’s pro-life agenda, including through dismissing criminal prosecutions and civil lawsuits against peaceful pro-life advocates targeted by the previous administration, and using the FACE Act to protect pro-life pregnancy centers,&#8221; a spokesman told The Daily Wire. &#8220;In this filing, the Department of Justice simply requested more time from the court for the FDA to complete its review of mifepristone REMS. As the Supreme Court recognized in a unanimous ruling less than two years ago, it is the role of the FDA – not the federal courts – to evaluate drug safety data and impose appropriate precautions.”
The department asserted that neither Louisiana nor Markezich was facing any immediate harm from the current regulations. The Alliance Defending Freedom, which is defending Markezich, disagreed. 
“Since Roe v. Wade was overturned in 2022, the Biden-era abortion-by-mail scheme has allowed thousands of abortion drugs to flow into Louisiana each year. We&#8217;re calling on the FDA to put a stop to it,” ADF wrote on X. “Yesterday, they submitted their reply brief in our lawsuit, Louisiana v. FDA. With [Louisiana Attorney General Liz Murrill] we’re asking the Court to end illegal mail-order abortions now. They agree that Biden’s scheme is unlawful, but they want to spend another year or more conducting a study. Justice delayed is justice denied. Stand with Rosalie and the State of Louisiana.”
Murrill <a href="https://x.com/AGLizMurrill/status/2016566792412365188">said</a> that the filing shows that the FDA admits the current regulations are “flawed but claims that Louisiana can’t sue to stop the 1,000 dangerous abortions a month in Louisiana that the REMS allows. That is an affront to our sovereignty and the dignity of women and the unborn. FDA should stand with us for life, not with [Gavin Newsom] and [Kathy Hochul].”
The filing was also criticized by Susan B. Anthony Pro-Life America, which has called for Makary’s ousting over his handling of the abortion pill study. 
“Today’s denial of justice by the DOJ is completely unacceptable. It slams the door on women like Rosalie Markezich and their babies, who are suffering very real harm as the Trump-Vance administration refuses to reimplement basic guardrails on deadly mail-order abortion drugs,” said SBA Pro-Life America President Marjorie Dannenfelser. “Abortion drugs accessible by mail are killing more Americans than fentanyl, cocaine or heroin combined.”
The FDA told The Daily Wire that it does not comment on pending litigation as a matter of policy.

HHS Secretary RFK Jr. Holds Press Conference On Protecting Children From Harmful Medical Interventions

FDA Claims Mail-Order Abortion Policies Are Not Preventing States From Protecting The Unborn

FDA Says Mail-Order Abortion Policies Not Preventing States From Protecting The Unborn

Alliance Defending Freedom (ADF)

Department of Justice

Louisiana

Democratic Governor Tim Walz and President Donald Trump have a “productive” conversation as border czar Tom Homan heads to Minnesota, the Minneapolis protests reveal an organized network, and the Food and Drug Administration moves to bring more medication out from behind the counter.
It’s Tuesday, January 27, 2026, and this is the news you need to know to start your day. Today’s edition of the Morning Wire podcast can be heard below:
<iframe style="width: 100%; max-width: 660px; overflow: hidden; border-radius: 10px;" src="https://embed.podcasts.apple.com/us/podcast/trump-walz-d%C3%A9tente-anti-ice-protest-network-exposed-1-27-26/id1576594336?i=1000746829901" height="175" frameborder="0" sandbox="allow-forms allow-popups allow-same-origin allow-scripts allow-storage-access-by-user-activation allow-top-navigation-by-user-activation"></iframe>
<h2 style="text-align: center;">Trump Dispatches Tom Homan To Minnesota</h2>
Amid continued protests, Minnesota Democratic Governor Tim Walz spoke with President Trump, and both parties described the conversation as productive. Meanwhile, the president has sent his border czar, Tom Homan, to help head up the operation in the city. The situation remains tense, however. The protests have ebbed and flowed, but as viral footage from Monday shows, agitators continue to wreak havoc in some areas. In one particularly wild situation in St. Paul, a group of anti-ICE agitators <a href="https://x.com/BMWQQ17/status/2015654020086464966">attempted</a> to break into a Home2Suites, where they thought immigration agents were staying. There was only one officer there to fend off the mob. That Bureau of Prisons officer ended up bloodied and <a href="https://x.com/LeftismForU/status/2015649706869706809">asking</a> where in the world were the local police? Several sources within the federal government told <a href="https://www.dailywire.com/news/inside-the-trump-administrations-growing-divide-over-mass-deportation-raids">The Daily Wire</a> that they’re happy Homan will be coming because they’re losing trust in Homeland Security Secretary Kristi Noem – not only because of her rush to call Alex Pretti a “domestic terrorist,” but also her assertion he showed up armed and with ammo on Saturday &#8220;to inflict maximum damage on individuals and to kill law enforcement.&#8221;
<h2 style="text-align: center;">Minneapolis Protestor Network Exposed</h2>
After Border Patrol shot and killed 37-year-old ICU nurse Alex Pretti, questions are mounting about the sophisticated network behind anti-immigration enforcement demonstrations. The picture coming into focus is more structured activism operating through layered networks on the ground in Minneapolis. Some are local, some regional, and some are tied to national left-wing movements. The networks that <a href="https://www.foxnews.com/politics/far-left-network-helped-put-alex-pretti-harms-way-made-him-martyr">Pretti was reportedly involved with</a> rely heavily on encrypted messaging platforms, especially Signal, to coordinate movement in real time, essentially sharing locations of federal vehicles, hotels housing agents, and enforcement activity. According to the Signal materials leaked from these groups, protestors take shifts, and operations run 24/7, with dispatch calls maxing out at 50 people at a time. They divide their patrol zones into districts and guide &#8220;ICE chasers&#8221; on positioning.
<h2 style="text-align: center;">Expanding Over-The-Counter Drugs</h2>
The FDA has launched a new initiative to get more drugs available over the counter, moving away from the current “prescription-only” system. According to FDA Commissioner Dr. Marty Makary, there will still be safeguards on drugs as necessary; this will apply to the many drugs that could be safely accessed over the counter but currently aren’t. The goals are to lower healthcare costs by eliminating middlemen and to make it easier for people to get the medications they need. Makary told Morning Wire that the initiative is a “common sense reform that is long overdue,” addressing an archaic system, the prescription-only system, that is simply not working.

MRN_260127_V1

Morning Brief: Trump Deploys Homan, Anti-ICE Network Revealed, & Rx Shake-Up

Morning Brief: Homan To Minneapolis, Protest Network Exposed, And Expanding Over-The-Counter Meds

Minneapolis

Minnesota

Tom Homan

When the Food and Drug Administration announced that the agency would be removing the black-box warning from hormone replacement therapy, or HRT, women everywhere threw their hands up in celebration.
And rightly so. America’s health agencies are finally acknowledging that women are not simply “little men,” and that research and clinical care must account for a woman’s unique biology and hormonal fluctuations across every stage of life.
But amid the cheering, some important nuance is being overlooked. The FDA’s decision to remove the black-box warning from HRT is just one example of how recommendations offered without adequate context or distinction may do more harm than good.
The idea that estrogen supplementation is a cure-all for the symptoms women commonly experience during perimenopause and menopause — hot flashes, disrupted sleep, fatigue, muscle aches, inflammation, weight gain, bloating, and mood swings — is a myth.
Often, women are not suffering from a lack of estrogen, but from what <a href="https://www.healthygutgirl.com/">Kitty Martone</a>, a holistic health educator who works with women to <a href="https://www.facebook.com/groups/1426024567689906">navigate perimenopause and menopause</a>, refers to as <a href="https://www.amenclinics.com/blog/what-is-estrogen-dominance/">estrogen dominance</a> — a state in which estrogen outweighs progesterone, producing symptoms that look identical to low estrogen.
Estrogen does not act in isolation, but the details are rarely explained to women. To be tolerated well, estrogen must be balanced by adequate progesterone and supported by a healthy metabolic rate. For many women, progesterone is the first hormone to decline — often years before estrogen meaningfully drops — due to chronic stress, under-eating, thyroid suppression, and blood sugar instability.
This creates a common paradox: estrogen may appear “normal,” or even low, on a lab test, yet functionally feel excessive in the body because there is not enough progesterone to counterbalance its effects. Women are then told they are estrogen-deficient and prescribed more estrogen, while symptoms such as anxiety, insomnia, migraines, heavy or irregular bleeding, bloating, and inflammation intensify rather than improve.
In these cases, simply prescribing more estrogen does not resolve symptoms. In fact, it can make them worse.
These mechanisms were not understood properly during the Women’s Health Initiative study, which was abruptly halted in the early 2000s upon a suggested correlation between HRT and breast cancer as well as heart disease. In an effort to recover from the fallout of the highly <a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC10758198/">flawed study</a>, which caused millions of women to abandon hormone therapy altogether, the pendulum has swung in the opposite direction.
Cue the pharmaceutical ads: dancing women in sunflower meadows, singing about how wonderful life is with the latest HRT option. The fine print instructs women to “ask your doctor if it’s right for you,” but many doctors may not be properly equipped to offer nuanced guidance.
Over the past few decades, medical visits have been reduced to 15–20 minute symptom reviews that are translated into billing codes entered into a computer. While this system serves insurance and data collection, it fails to treat women as whole individuals. It leaves little room to explore how diet, stress, thyroid function, gut health, or metabolic status influence hormonal symptoms — particularly in perimenopausal women.
Martone argues that this system has created an environment where estrogen is prescribed casually, without sufficient context. “Doctors now essentially have carte blanche to prescribe estrogen for any hormone complaint — without evaluating detox pathways, metabolism, liver function, or estrogen clearance.”
Some clinicians have been cautioning against this oversimplification for decades. <a href="https://raypeat.com/">Dr. Ray Peat</a>, who studied hormones, metabolism, and stress physiology extensively, <a href="https://raypeat.com/articles/aging/aging-estrogen-progesterone.shtml">wrote about</a> how estrogen tends to accumulate under conditions of chronic stress and low thyroid function, while progesterone plays a stabilizing, protective role for both the nervous system and bodily tissues.
In plain terms, how a woman feels on hormones can have less to do with hormone levels and more to do with improper functioning of the liver, metabolism, and stress load at the time therapy is introduced. Two women can take the same prescription and have completely different outcomes — not because one is “doing it wrong,” but because their internal terrain is different.
This helps explain why so many women feel dismissed when HRT is presented as a simple solution. When symptoms worsen, they are often told to increase the dose or switch brands, rather than step back and ask whether the body is prepared to handle additional estrogen.
Martone emphasizes that women often need to experiment with hormones to discover individualized therapies that are right for them. Even low doses may require careful adjustment, alternative delivery methods, and significant trial and error — an experience that can be costly, frustrating, and far from straightforward.
Meanwhile, big pharmaceutical companies are circling middle-aged women like sharks around blood. With the FDA’s decision, they’ve gained an expanded customer base — one encouraged to start hormone therapy earlier and remain on it for decades.
The truth is no one — not even a doctor — can predict exactly how a woman will respond to HRT. Hormones are powerful biological signals, not cosmetic fixes. Their effects depend heavily on the body’s metabolic health, stress physiology, and ability to process and clear them.
The renewed interest in hormone therapy reflects a real and valid desire for relief for women. But before removing warning labels and declaring HRT a universal solution, it’s worth asking why those cautions existed in the first place.
Hormone replacement therapy is not a magic bullet. Women deserve care that honors complexity, not just convenience.
* * *
Jennifer Galardi is a Senior Policy Analyst for Restoring American Wellness in Heritage’s DeVos Center.
The views expressed in this piece are those of the author and do not necessarily represent those of The Daily Wire.

Nurse talks with female patient about prescription medication

What The FDA Doesn’t Tell Women About Hormone Replacement Therapy

Big Pharma

Doctors

Health Care

Heritage Foundation

Pharmaceuticals

Women

In the post-Roe landscape, pro-life advocates can now effectively work to impose tough restrictions on abortions in states across the nation – but it’s not enough. And that has everything to do with the proliferation of the <a href="https://www.dailywire.com/news/despite-dobbs-more-babies-are-still-being-aborted-in-the-united-states">abortion pill mifepristone</a>, and how it continues to be prescribed throughout the nation. 
“This is the Wild West, and this is the greatest public health crisis,” Live Action founder Lila Rose told The Daily Wire on Thursday. “The on-demand sale of the abortion pill via our mail system is the biggest public health crisis that we are facing.”
Restrictions on the pill have become wildly lax. During the Biden years, for example, mifepristone was permitted to be sent through the mail. Now, more than 60% of all abortions include abortion pills, a significant increase from past years. 
Pro-lifers want the pill taken off the market, not only for killing unborn humans, but because of how dangerous they say the pill is for women, especially when guardrails are virtually nonexistent. 
“There are thousands of women going to the emergency room with severe health complications, and sometimes life-threatening health complications because of the abortion pill,” Rose said. “There are hundreds of thousands of children being killed in this country annually by the abortion pill. It&#8217;s our biggest public health crisis.”
“The report from the Ethics and Public Policy Center proves that one out of every 24 women are landing in the emergency room, that there are severe health complications for one out of every 10 women,” Rose continued. “<a href="https://www.liveaction.org/news/live-action-investigative-report-video-abortion-pill">Live Action’s investigation</a> that just broke [Thursday] proves that Planned Parenthood is not checking gestational age, they are not providing ultrasounds. They are sending pills across state lines, sending them to the homes of friends of the person who is supposedly purchasing the pill with no follow-up care.”
As The Daily Wire’s Leif Le Mahieu previously <a href="https://www.dailywire.com/news/despite-dobbs-more-babies-are-still-being-aborted-in-the-united-states">reported</a>, abortions have continued to rise since 2023. The increase can largely be pinned on abortion-by-mail, even in states with “abortion bans” in place. 
While pro-life advocates like Rose give high praise to the Trump administration for a number of big pro-life victories, they believe the Food and Drug Administration (FDA) can do more to address the proliferation of the abortion pill. 
“The FDA can, in a moment, make a rule to ensure that the abortion pill requires at least one doctor&#8217;s visit,” Rose said. “There used to be three required doctor&#8217;s visits, and this was under the Clinton administration, when the pill was illegally under an emergency order fast-tracked in this country and put on the market. So that&#8217;s something the FDA could do tomorrow.”
“The FDA could pull mifepristone used as an abortifacient from the market tomorrow. Approval for that could happen within 24 hours – the administration has everything they need,” she said, adding that state-level data can be reviewed by the FDA. 
Speaking to The Daily Wire on Wednesday, FDA Commissioner Dr. Marty Makary stressed that a comprehensive review of the pill is something that will be done, and is currently in the data acquisition phase. However, he said, the science takes time. 
“Some people think that study can be done overnight, but a proper study at any university takes time,” Makary said. “This is, in fact, my background at Johns Hopkins for 22 years. Being on the faculty, we did many of these large studies and sometimes they took a year if we did them right. Now, in the government, there are some delays associated with procurement, acquiring databases – and the government shutdown was definitely a bit of a setback.”
“But we are committed to getting this study done expeditiously, and I can assure you that there are no attempts to delay any such study,” he said. “People deserve to know the answer.”
Hundreds of thousands of pro-lifers are expected in Washington, D.C. Friday for the annual March for Life, where mifepristone will certainly be a topic of discussion. But so will major pro-life wins, which come in large part due to the Trump administration. 
Just one day before the rally, for example, the National Institutes of Health announced that it will end, effective immediately, the use of abortion-derived human fetal tissue in federally-funded research, <a href="https://www.dailywire.com/news/exclusive-trump-admin-ends-funding-for-research-using-aborted-baby-tissue?author=Mary+Margaret+Olohan&amp;category=News&amp;elementPosition=undefined&amp;row=0&amp;rowType=Vertical+List&amp;title=Ahead+Of+March+For+Life%2C+Trump+Admin+Ends+Funding+For+Research+Using+Aborted+Baby+Tissue">The Daily Wire</a> first reported. 
“The only ban is on, you have an abortion specifically to terminate the baby, and then the tissue then gets sold, that’s what’s being banned,” NIH Director Jay Bhattacharya told Daily Wire Editor Emeritus Ben Shapiro on Thursday. If someone wants to donate tissue from a miscarriage, the NIH can use that for research, he noted. 
“Now that there is better technology, there’s no scientific harm to this, we’re still going to be able to use the science we need, … while at the same time getting rid of this use of aborted fetal tissue which so many people, including me, find morally abhorrent,” Bhattacharya added. 
Rose also praised the Trump administration for major pro-life victories. 
“Certainly the pardoning of the pro-life prisoners last year was a huge win by President Trump,” she told The Daily Wire. “It was also a huge win for Congress to finally remove federal funding from Planned Parenthood for one year – and that was signed, of course, by President Trump. … There have been dozens of Planned Parenthood facilities that are shut down because of the lack of taxpayer funding. Those are historic wins for the movement.”

Demonstrators protest and argue outside the U.S. Supreme

The Battle Over The Abortion Pill 

Dobbs

Mifepristone

An undercover video released by Live Action ahead of the March for Life appears to show a Planned Parenthood employee telling a woman that ending the life of an unborn child is safer than giving birth.
Investigators with Live Action released an undercover video on Thursday that appears to show Planned Parenthood employees being willing to covertly ship abortion pills, and agreeing to ship pills without confirming the gestational age of the child. The video was released as part of an effort to urge the Trump administration to take action to stop the widespread mailing of the abortion drug across the country.
For the video, Live Action said it made calls to 27 different Planned Parenthood affiliates across the country and asked a number of questions about receiving the abortion drug mifepristone. The video featured recordings of the calls with investigators and Planned Parenthood employees.
In one of the calls, an employee at a Planned Parenthood in Brooklyn Park, Minnesota, tells a woman it would be safer for her to end the life of her unborn child through an in-person abortion or abortion pill than to deliver it.
“I mean, I would say like both procedures are really safe and effective, but as with any medical procedure, there are some risks involved,” the employee says in the video, according to Live Action. “Of course, you know, we can talk about that more in detail with, like, a medical care provider just to get more accurate info on that, if that makes sense. But I know they’re like, they’re like, certainly like, safer than, like, you know, carrying to term, I’d say as far as that goes.”  
<blockquote class="twitter-tweet" data-media-max-width="560">
NEW Live Action undercover exposé into Planned Parenthood 🚨
We called Planned Parenthood undercover to expose their reckless distribution of the abortion pill.
Here&#8217;s what we found:<a href="https://twitter.com/FDA?ref_src=twsrc%5Etfw">@FDA</a> <a href="https://twitter.com/VP?ref_src=twsrc%5Etfw">@VP</a> <a href="https://twitter.com/POTUS?ref_src=twsrc%5Etfw">@POTUS</a> <a href="https://t.co/lZUwCU1UCa">pic.twitter.com/lZUwCU1UCa</a>
— Live Action (@LiveAction) <a href="https://twitter.com/LiveAction/status/2014367975554556078?ref_src=twsrc%5Etfw">January 22, 2026</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script>
In another video from St. Cloud, Minnesota, a Planned Parenthood employee said to a woman that she couldn’t quite tell her what she would see after taking abortion pills.
“You’re pregnant, so the abortion, you will be bleeding and cramping and blood clots to get rid of the pregnancy or get rid of the baby, you know, the pregnancy,” the person said on the call.
In other videos, individuals identified as Planned Parenthood employees by Live Action told women they wouldn’t need to get ultrasounds before getting mailed abortion pills or need follow-up appointments after taking the pills.
“Do I have to have an ultrasound?” the Live Action investigator asks a person identified as a Planned Parenthood employee in Santa Fe, New Mexico.
“So, if you don’t want an ultrasound, if you’re OK not getting one, we can go ahead and move forward,” the unidentified employee responded, according to the recording published by Live Action.
In Portland, the investigator was told she could get the pills sent to her in a “confidential manner.”
“Can I do this without my parents knowing?” the Live Action investigator asked.
“Yeah, we can set it up to be confidential for you,” the Planned Parenthood employee responded.
Other investigators were told that the pills don’t “have to go right to your house” and that Planned Parenthood could “use a different address, you can put like a friend’s address or something.”
The video was released at a press conference attended by multiple Republican lawmakers, including Reps. Michael Cloud (R-TX), Mark Harris (R-NC), Troy Downing (R-MT), and Andy Biggs (R-AZ).
When reached for comment on the video, Planned Parenthood did not respond to the specific allegations but claimed to comply with all applicable laws.
“Planned Parenthood health centers that offer medication abortion follow all applicable laws and regulations and always ensure care provided reflects the latest credible research and upholds the highest standard of patient care,” Danika Severino of Planned Parenthood told The Daily Wire.
&#8220;In accordance with Planned Parenthood Federation of America’s medical standards and guidelines — which are developed and updated with medical experts across the field of sexual and reproductive health care using rigorous scientific evidence — providers at Planned Parenthood health centers explain the associated risks and benefits to patients seeking medication abortion, just as they do with every health care service provided,” she added.
The video was published in conjunction with the release of a <a href="https://dw-wp-production.imgix.net/2026/01/LA26-The-State-of-Chemical-Abortion-01.20.26-updated.pdf">report</a> detailing the history and dangers of the abortion pill and a letter to Health and Human Services Secretary Robert F. Kennedy Jr. and Food and Drug Administration Commissioner Marty Makary.
“Since its approval in 2000, this drug has ended the lives of approximately 7.5 million children in the United States. Live Action’s investigation now publicly documents how those regulatory failures in safety manifest in clinical practice, particularly within Planned Parenthood facilities tasked with administering this drug under federal safeguards,” Live Action President Lila Rose wrote to Kennedy and Makary.
Rose asked the officials to “reevaluate the approval and current regulatory status of mifepristone, strengthen transparency and data collection, and remove this dangerous drug from the market.”
On Thursday, Rose met with Kennedy and said that they <a href="https://x.com/LilaGraceRose/status/2014396553406886052">discussed</a> the “dangers of the abortion pill.”
Ahead of the March for Life, the Trump administration did make multiple pro-life policy moves that were praised by conservative groups. The administration ended the use of human fetal tissue in federally-funded research, expanded the Mexico City policy, cutting funding for abortion abroad, and took actions to protect the rights of doctors in Illinois to not perform abortions.
Those moves were praised by the Susan B. Anthony Pro-Life America organization, which also demanded that they reverse Biden-era guidelines that allowed the abortion pill to be sent through the mail. These regulations have enabled activists to ship abortion pills into states where medication abortions are technically illegal.
“The abortion rate has gone way up over a million at least as far as we can track,” SBA Pro-Life America President Marjorie Dannenfelser said on a press call attended by The Daily Wire. “They&#8217;re going up in these states because the abortion drugs, of course, through the mail, anyone can order them, they&#8217;re flooding [to] every boyfriend, every trafficker, every woman who orders them.”

Bill Tompkins  Planned Parenthood signage Archive

Planned Parenthood Employee Says Abortion ‘Safer’ Than Birth In Undercover Call

Menu

FDA